819 related articles for article (PubMed ID: 21976740)
21. Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose.
Chishti AS; Sorof JM; Brewer ED; Kale AS
Am J Kidney Dis; 2001 Oct; 38(4):754-60. PubMed ID: 11576878
[TBL] [Abstract][Full Text] [Related]
22. Steroid resistant focal segmental glomerulosclerosis: effect of arterial hyalinosis on outcome: single center study.
Soliman AR; Maamoun H; Soliman H; Ahmed RM
Rom J Intern Med; 2021 Jun; 59(2):127-133. PubMed ID: 33565308
[No Abstract] [Full Text] [Related]
23. Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study.
Senthil Nayagam L; Ganguli A; Rathi M; Kohli HS; Gupta KL; Joshi K; Sakhuja V; Jha V
Nephrol Dial Transplant; 2008 Jun; 23(6):1926-30. PubMed ID: 17989103
[TBL] [Abstract][Full Text] [Related]
24. Steroid-resistant nephrotic syndrome: long-term evolution after sequential therapy.
Peña A; Bravo J; Melgosa M; Fernandez C; Meseguer C; Espinosa L; Alonso A; Picazo ML; Navarro M
Pediatr Nephrol; 2007 Nov; 22(11):1875-80. PubMed ID: 17876609
[TBL] [Abstract][Full Text] [Related]
25. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study.
Ghiggeri GM; Catarsi P; Scolari F; Caridi G; Bertelli R; Carrea A; Sanna-Cherchi S; Emma F; Allegri L; Cancarini G; Rizzoni GF; Perfumo F
Clin Ther; 2004 Sep; 26(9):1411-8. PubMed ID: 15531003
[TBL] [Abstract][Full Text] [Related]
26. Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil.
Gellermann J; Querfeld U
Pediatr Nephrol; 2004 Jan; 19(1):101-4. PubMed ID: 14753204
[TBL] [Abstract][Full Text] [Related]
27. Mycophenolate mofetil for sustained remission in nephrotic syndrome.
Querfeld U; Weber LT
Pediatr Nephrol; 2018 Dec; 33(12):2253-2265. PubMed ID: 29750317
[TBL] [Abstract][Full Text] [Related]
28. Positive role of rituximab in switching from cyclosporine to mycophenolate mofetil for children with high-dose steroid-dependent nephrotic syndrome.
Fujinaga S; Sakuraya K; Yamada A; Urushihara Y; Ohtomo Y; Shimizu T
Pediatr Nephrol; 2015 Apr; 30(4):687-91. PubMed ID: 25576066
[TBL] [Abstract][Full Text] [Related]
29. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
Wang J; Mao J; Chen J; Fu H; Shen H; Zhu X; Liu A; Shu Q; Du L
Nephrology (Carlton); 2016 Jan; 21(1):21-7. PubMed ID: 26697959
[TBL] [Abstract][Full Text] [Related]
31. Immunosuppressive therapy in children with primary nephrotic syndrome: single center experience, Karachi, Pakistan.
Moorani KN; Hotchandani HM; Zubair AM; Lohana NC; Veerwani NR
BMC Nephrol; 2019 Jul; 20(1):239. PubMed ID: 31269922
[TBL] [Abstract][Full Text] [Related]
32. Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.
Ladapo TA; Esezobor CI; Lesi FE
Pan Afr Med J; 2016; 25():258. PubMed ID: 28293374
[TBL] [Abstract][Full Text] [Related]
33. Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine.
Hino S; Takemura T; Okada M; Murakami K; Yagi K; Fukushima K; Yoshioka K
Am J Kidney Dis; 1998 Jun; 31(6):932-9. PubMed ID: 9631836
[TBL] [Abstract][Full Text] [Related]
34. Combination of immunosuppressive agents in treatment of steroid-resistant minimal change disease and primary focal segmental glomerulosclerosis.
El-Reshaid K; El-Reshaid W; Madda J
Ren Fail; 2005; 27(5):523-30. PubMed ID: 16152989
[TBL] [Abstract][Full Text] [Related]
35. [Comparison of therapeutic effects of prednisone combined with mycophenolate mofetil versus cyclosporin A in children with steroid-resistant nephrotic syndrome].
Li ZH; Lin Z; Duan CR; Wu TH; Xun M; Zhang Y; Zhang L; Ding YF; Yin Y
Zhongguo Dang Dai Er Ke Za Zhi; 2016 Feb; 18(2):130-5. PubMed ID: 26903059
[TBL] [Abstract][Full Text] [Related]
36. [Mycophenolate mofetil versus cyclosporine A in children with primary refractory nephrotic syndrome].
Geng HY; Ji LN; Chen CY; Tu J; Li HR; Bao R; Lin Y
Zhonghua Er Ke Za Zhi; 2018 Sep; 56(9):651-656. PubMed ID: 30180402
[No Abstract] [Full Text] [Related]
37. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
Mahmoud I; Basuni F; Sabry A; El-Husseini A; Hassan N; Ahmad NS; Elbaz M; Moustafa F; Sobh M
Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265
[TBL] [Abstract][Full Text] [Related]
38. Immunosupressive therapy in children with steroid-resistant nephrotic syndrome: single center experience.
Echeverri CV; Valencia GA; Higuita LM; Gayubo AK; Ochoa CL; Rosas LF; Muñoz LC; Sierra J; Zuleta JJ; Ruiz JJ
J Bras Nefrol; 2013; 35(3):200-5. PubMed ID: 24100739
[TBL] [Abstract][Full Text] [Related]
39. Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome.
Barletta GM; Smoyer WE; Bunchman TE; Flynn JT; Kershaw DB
Pediatr Nephrol; 2003 Aug; 18(8):833-7. PubMed ID: 12774223
[TBL] [Abstract][Full Text] [Related]
40. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T; Sako M; Nakanishi K; Ishikura K; Ito S; Nakamura H; Oba MS; Nozu K; Iijima K
BMC Nephrol; 2018 Nov; 19(1):302. PubMed ID: 30382824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
